United States Immune Globulin Subcutaneous Market Report 2018

March 2018 | 96 pages | ID: U9319DC3F0DEN
QYResearch

Abstracts

In this report, the United States Immune Globulin Subcutaneous market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Immune Globulin Subcutaneous in these regions, from 2013 to 2025 (forecast).

United States Immune Globulin Subcutaneous market competition by top manufacturers/players, with Immune Globulin Subcutaneous sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Baxter
• CSL

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• IVIg Liquid
• IVIg Powder

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Immunodeficiency
• Autoimmune Disease
• Acute Infection

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Immune Globulin Subcutaneous Market Report 2018

1 IMMUNE GLOBULIN SUBCUTANEOUS OVERVIEW

1.1 Product Overview and Scope of Immune Globulin Subcutaneous
1.2 Classification of Immune Globulin Subcutaneous by Product Category
  1.2.1 United States Immune Globulin Subcutaneous Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Immune Globulin Subcutaneous Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 IVIg Liquid
  1.2.4 IVIg Powder
1.3 United States Immune Globulin Subcutaneous Market by Application/End Users
  1.3.1 United States Immune Globulin Subcutaneous Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Immunodeficiency
  1.3.3 Autoimmune Disease
  1.3.4 Acute Infection
1.4 United States Immune Globulin Subcutaneous Market by Region
  1.4.1 United States Immune Globulin Subcutaneous Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Immune Globulin Subcutaneous Status and Prospect (2013-2025)
  1.4.3 Southwest Immune Globulin Subcutaneous Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Immune Globulin Subcutaneous Status and Prospect (2013-2025)
  1.4.5 New England Immune Globulin Subcutaneous Status and Prospect (2013-2025)
  1.4.6 The South Immune Globulin Subcutaneous Status and Prospect (2013-2025)
  1.4.7 The Midwest Immune Globulin Subcutaneous Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Immune Globulin Subcutaneous (2013-2025)
  1.5.1 United States Immune Globulin Subcutaneous Sales and Growth Rate (2013-2025)
  1.5.2 United States Immune Globulin Subcutaneous Revenue and Growth Rate (2013-2025)

2 UNITED STATES IMMUNE GLOBULIN SUBCUTANEOUS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Immune Globulin Subcutaneous Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Immune Globulin Subcutaneous Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Immune Globulin Subcutaneous Average Price by Players/Suppliers (2013-2018)
2.4 United States Immune Globulin Subcutaneous Market Competitive Situation and Trends
  2.4.1 United States Immune Globulin Subcutaneous Market Concentration Rate
  2.4.2 United States Immune Globulin Subcutaneous Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Immune Globulin Subcutaneous Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES IMMUNE GLOBULIN SUBCUTANEOUS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Immune Globulin Subcutaneous Sales and Market Share by Region (2013-2018)
3.2 United States Immune Globulin Subcutaneous Revenue and Market Share by Region (2013-2018)
3.3 United States Immune Globulin Subcutaneous Price by Region (2013-2018)

4 UNITED STATES IMMUNE GLOBULIN SUBCUTANEOUS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Immune Globulin Subcutaneous Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Immune Globulin Subcutaneous Revenue and Market Share by Type (2013-2018)
4.3 United States Immune Globulin Subcutaneous Price by Type (2013-2018)
4.4 United States Immune Globulin Subcutaneous Sales Growth Rate by Type (2013-2018)

5 UNITED STATES IMMUNE GLOBULIN SUBCUTANEOUS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Immune Globulin Subcutaneous Sales and Market Share by Application (2013-2018)
5.2 United States Immune Globulin Subcutaneous Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES IMMUNE GLOBULIN SUBCUTANEOUS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Baxter
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Immune Globulin Subcutaneous Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Baxter Immune Globulin Subcutaneous Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 CSL
  6.2.2 Immune Globulin Subcutaneous Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 CSL Immune Globulin Subcutaneous Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview

7 IMMUNE GLOBULIN SUBCUTANEOUS MANUFACTURING COST ANALYSIS

7.1 Immune Globulin Subcutaneous Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Immune Globulin Subcutaneous

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Immune Globulin Subcutaneous Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Immune Globulin Subcutaneous Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES IMMUNE GLOBULIN SUBCUTANEOUS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Immune Globulin Subcutaneous Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Immune Globulin Subcutaneous Sales Volume Forecast by Type (2018-2025)
11.3 United States Immune Globulin Subcutaneous Sales Volume Forecast by Application (2018-2025)
11.4 United States Immune Globulin Subcutaneous Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Immune Globulin Subcutaneous
Figure United States Immune Globulin Subcutaneous Market Size (K Units) by Type (2013-2025)
Figure United States Immune Globulin Subcutaneous Sales Volume Market Share by Type (Product Category) in 2017
Figure IVIg Liquid Product Picture
Figure IVIg Powder Product Picture
Figure United States Immune Globulin Subcutaneous Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Immune Globulin Subcutaneous by Application in 2017
Figure Immunodeficiency Examples
Table Key Downstream Customer in Immunodeficiency
Figure Autoimmune Disease Examples
Table Key Downstream Customer in Autoimmune Disease
Figure Acute Infection Examples
Table Key Downstream Customer in Acute Infection
Figure United States Immune Globulin Subcutaneous Market Size (Million USD) by Region (2013-2025)
Figure The West Immune Globulin Subcutaneous Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Immune Globulin Subcutaneous Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Immune Globulin Subcutaneous Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Immune Globulin Subcutaneous Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Immune Globulin Subcutaneous Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Immune Globulin Subcutaneous Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Immune Globulin Subcutaneous Sales (K Units) and Growth Rate (2013-2025)
Figure United States Immune Globulin Subcutaneous Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Immune Globulin Subcutaneous Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Immune Globulin Subcutaneous Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Immune Globulin Subcutaneous Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Immune Globulin Subcutaneous Sales Share by Players/Suppliers
Figure 2017 United States Immune Globulin Subcutaneous Sales Share by Players/Suppliers
Figure United States Immune Globulin Subcutaneous Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Immune Globulin Subcutaneous Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Immune Globulin Subcutaneous Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Immune Globulin Subcutaneous Revenue Share by Players/Suppliers
Figure 2017 United States Immune Globulin Subcutaneous Revenue Share by Players/Suppliers
Table United States Market Immune Globulin Subcutaneous Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Immune Globulin Subcutaneous Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Immune Globulin Subcutaneous Market Share of Top 3 Players/Suppliers
Figure United States Immune Globulin Subcutaneous Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Immune Globulin Subcutaneous Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Immune Globulin Subcutaneous Product Category
Table United States Immune Globulin Subcutaneous Sales (K Units) by Region (2013-2018)
Table United States Immune Globulin Subcutaneous Sales Share by Region (2013-2018)
Figure United States Immune Globulin Subcutaneous Sales Share by Region (2013-2018)
Figure United States Immune Globulin Subcutaneous Sales Market Share by Region in 2017
Table United States Immune Globulin Subcutaneous Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Immune Globulin Subcutaneous Revenue Share by Region (2013-2018)
Figure United States Immune Globulin Subcutaneous Revenue Market Share by Region (2013-2018)
Figure United States Immune Globulin Subcutaneous Revenue Market Share by Region in 2017
Table United States Immune Globulin Subcutaneous Price (USD/Unit) by Region (2013-2018)
Table United States Immune Globulin Subcutaneous Sales (K Units) by Type (2013-2018)
Table United States Immune Globulin Subcutaneous Sales Share by Type (2013-2018)
Figure United States Immune Globulin Subcutaneous Sales Share by Type (2013-2018)
Figure United States Immune Globulin Subcutaneous Sales Market Share by Type in 2017
Table United States Immune Globulin Subcutaneous Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Immune Globulin Subcutaneous Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Immune Globulin Subcutaneous by Type (2013-2018)
Figure Revenue Market Share of Immune Globulin Subcutaneous by Type in 2017
Table United States Immune Globulin Subcutaneous Price (USD/Unit) by Types (2013-2018)
Figure United States Immune Globulin Subcutaneous Sales Growth Rate by Type (2013-2018)
Table United States Immune Globulin Subcutaneous Sales (K Units) by Application (2013-2018)
Table United States Immune Globulin Subcutaneous Sales Market Share by Application (2013-2018)
Figure United States Immune Globulin Subcutaneous Sales Market Share by Application (2013-2018)
Figure United States Immune Globulin Subcutaneous Sales Market Share by Application in 2017
Table United States Immune Globulin Subcutaneous Sales Growth Rate by Application (2013-2018)
Figure United States Immune Globulin Subcutaneous Sales Growth Rate by Application (2013-2018)
Table Baxter Basic Information List
Table Baxter Immune Globulin Subcutaneous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Baxter Immune Globulin Subcutaneous Sales Growth Rate (2013-2018)
Figure Baxter Immune Globulin Subcutaneous Sales Market Share in United States (2013-2018)
Figure Baxter Immune Globulin Subcutaneous Revenue Market Share in United States (2013-2018)
Table CSL Basic Information List
Table CSL Immune Globulin Subcutaneous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure CSL Immune Globulin Subcutaneous Sales Growth Rate (2013-2018)
Figure CSL Immune Globulin Subcutaneous Sales Market Share in United States (2013-2018)
Figure CSL Immune Globulin Subcutaneous Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immune Globulin Subcutaneous
Figure Manufacturing Process Analysis of Immune Globulin Subcutaneous
Figure Immune Globulin Subcutaneous Industrial Chain Analysis
Table Raw Materials Sources of Immune Globulin Subcutaneous Major Players/Suppliers in 2017
Table Major Buyers of Immune Globulin Subcutaneous
Table Distributors/Traders List
Figure United States Immune Globulin Subcutaneous Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Immune Globulin Subcutaneous Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Immune Globulin Subcutaneous Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Immune Globulin Subcutaneous Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Immune Globulin Subcutaneous Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Immune Globulin Subcutaneous Sales Volume (K Units) Forecast by Type in 2025
Table United States Immune Globulin Subcutaneous Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Immune Globulin Subcutaneous Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Immune Globulin Subcutaneous Sales Volume (K Units) Forecast by Application in 2025
Table United States Immune Globulin Subcutaneous Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Immune Globulin Subcutaneous Sales Volume Share Forecast by Region (2018-2025)
Figure United States Immune Globulin Subcutaneous Sales Volume Share Forecast by Region (2018-2025)
Figure United States Immune Globulin Subcutaneous Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources